Aurobindo Pharma

Growth Markets

At Aurobindo Pharma, we are committed to providing advanced medicines across various therapeutic areas at affordable prices. Our vision is to become a leading and admired global pharma company and our Mission is to become the most valued pharma partner in the world of pharma fraternity by continuously researching and developing.

With most of the world's population concentrated in Growth Markets (GM), the GM countries are witnessing a rising middle class and a shift towards universal healthcare coverage. The pharma growth markets are projected to grow at 5.8-7.2% during 2023-2027¹

Aurobindo Pharma is uniquely positioned to meet the growing needs of the GM with its 29 state-of-the-art manufacturing and packaging facilities, 9 R&D centers, 1,500+ scientists and analysts involved in R&D.

Aurobindo Pharma has 2,000+ products registered across more than 50 GM countries. Our portfolio in GM has evolved over the years based on the prevalent diseases, beginning with anti-infectives, followed by medicines for Cardiovascular, Gastrointestinal, Central Nervous system and Metabolic disorders. With the rising trend in lifestyle diseases and increase in the per capita income, there has been a surge in the incidence of malignancies. Aurobindo Pharma has an impressive portfolio of 50+ oncology medicines for different types of cancers.

As a responsible Healthcare company, we organize a host of activities; both for the Healthcare professionals (HCPs) and for the patients. For HCP's, we regularly conduct 'Continuing Medical Education' (CMEs) programs and Medical Journal subscriptions. We are pioneers in the propagation of rational use of antibiotics with our AMR newsletter. On the patient front, we are actively involved in disease awareness programs for mental health and cancer care.

We take great pride to be associated with some of the renowned bodies like 'Clinton Health Access Initiative' (CHAI), UNICEF, UNDP and recently with Medicines Patent Pool (MPP) to provide quality medicines at affordable prices. With a vast product portfolio, backed by dedicated R&D and quality manufacturing facilities, we are committed to provide innovative and affordable medicines in GM for healthier patient outcomes.